Krystal Biotech Shares Tumble 10% on Wider 2Q Loss
By Denny Jacob Krystal Biotech shares tumbled 10% to $111.67 following a wider loss in its latest quarter. The stock is up 42% on the year. The...
Krish Krishnan Denny Jacob Drug Administration Executive Krish Krishnan Article Normal Biotechnology Services
Source: marketwatch.com